During a recent investor call, Elon Musk reportedly hinted at a major valuation adjustment for his artificial intelligence startup, with the Tesla and SpaceX CEO stating that he was looking to put a “proper value” on xAI.
The report was initially shared by CNBC’s David Faber during a segment on the Faber Report.
Investor Call Sparks Speculation
Citing sources who were reportedly involved in the call, Faber noted that while Musk did not specifically state that he was looking to initiate another funding round, his comments about a “proper valuation” for xAI were interpreted by Faber’s sources that xAI may be setting the stage for a notable capital raise in the near future.
“Let me give you some takeaways from the call itself. It was with a number of the companies, the investors in xAI going over a number of important things, that included the closing of the X transaction… Remember, xAI and X are now one company valuing X at $33 billion going in. xAI had a value of as much as $80 billion.
“What I’ve heard is the company is setting up for another capital raise of great significance… But on the call, Musk is quoted as having said, ‘We’re going to put a proper value on the company in reference to xAI,’ and people took that to mean, and again this is speculation, that they will have a large raise,” Faber stated.
xAI’s Growth and Ambitions
Launched in July 2023, xAI introduced its Grok chatbot to challenge Anthropic’s Claude and OpenAI’s ChatGPT. In March, Musk merged xAI with X. “xAI and X’s futures are intertwined,” Musk wrote on X. “Today, we officially take the step to combine the data, models, compute, distribution and talent.”
The merger leverages X’s data to train Grok, boosting xAI’s competitive edge. xAI has also made a lot of headway in the artificial intelligence space, thanks in part to its speed, which allowed it to set up Colossus, a supercomputer cluster comprised of 100,000 GPUs, in just 122 days. Colossus has since been expanded to 200,000 GPUs, and plans are underway to expand the supercomputer even further.
AloJapan.com